On assessing survival benefit of immunotherapy using long‐term restricted mean survival time (Q61029): Difference between revisions
From MaRDI portal
Normalize DOI. |
Normalize DOI. |
||
| Property / DOI | |||
| Property / DOI: 10.1002/SIM.9662 / rank | |||
| Property / DOI | |||
| Property / DOI: 10.1002/SIM.9662 / rank | |||
Normal rank | |||
Latest revision as of 19:59, 27 December 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | On assessing survival benefit of immunotherapy using long‐term restricted mean survival time |
scientific article |
Statements
42
0 references
8
0 references
1139-1155
0 references
18 January 2023
0 references
